Pakistan to import Chinese Cansino COVID vaccine in bulk to package 3 million doses locally: MinisterPakistan expects to receive one million doses of Sinopharm vaccine in a couple of days.
Pakistan to start importing CanSino COVID-19 vaccine for commercial sale this weekPakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the com...
Pakistan not planning to buy COVID-19 vaccines; to rely on herd immunity and donated jabsSo far, four vaccines -Sinophram (China), Oxford-AstraZeneca (UK), Sputnik-V (Russia) and Cansino Bio (China) have been registered in the c...
Pakistan approves fourth COVID-19 vaccineChinese company Cansino Biologics Inc's vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday.
Lancet peer-reviewed study endorses Russia's Sputnik V Covid-19 vaccineSputnik V uses two adenoviruses, AD 5 and AD 26, that target the spike protein of the SARS Cov2 virus. Companies such as AstraZeneca, Johns...
Pakistan: China to gift half million doses of Sinopharm vaccine"They have said send your aircraft and airlift this vaccine immediately. So this is a happy bit of news for us, and we will hopefully be su...
China's COVID-19 vaccine makers apply to join COVAX schemeThe COVAX scheme - led by the World Health Organization and GAVI vaccine alliance - is due to start rolling out vaccines to poor and middle...
Pakistan approves initial funds to purchase COVID-19 vaccineThe initial phase of vaccinations would focus on providing free shots for frontline health workers and people above the age of 65 years, Fa...
Covid-19 vaccine front-runner held back by China’s spat with CanadaChinese customs hasn’t approved shipments of CanSino’s vaccine to Canada, the National Research Council of Canada said in a Aug. 26 email. ...
Testing of China’s candidate vaccine begins in RussiaThe Ad5-nCoV vaccine already has approval for use by China’s military after early and mid-stage trials, and further late-stage trials are b...
No country for Chinese vaccine: China's big drug maker not able to conduct overseas trialsIf history is any guide, domestic use-only could be a path for China: An Ebola vaccine, also jointly developed by CanSino and the military ...
Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedyIn the situation of a grave pandemic engulfing almost all the countries alike, hopes for a cure have brightened with encouraging developmen...
How are new vaccines developed? Here is the complete processWhat do different phases of a trial test?Phase 1 and 2 test safety and immune response. Safety is one of the most important factors in a va...
China's CanSino in talks for COVID-19 vaccine Phase III trial overseasChina's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countri...
'At war time speed', China leads COVID-19 vaccine raceWhile a laggard in the global vaccine industry, China, where the new coronavirus is thought to have originated, has brought state, military...
How a Chinese firm jumped to the front of the virus vaccine raceIn May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...
China's Tianjin CanSino Biotechnology to mass produce Ebola vaccineInvestment into the base totals 2 billion yuan (about USD 317 million) and construction will be complete in September, 2018.